Table 4 Publication characteristics associated with abstract reporting completeness score
Publication characteristics | Number | Completeness score mean ± SD | P value |
|---|---|---|---|
Endorsement of CONSORT recommendations | 0.241 | ||
No | 30 | 8.7 ± 2.1 | |
Yes | 144 | 9.3 ± 2.9 | |
Placebo controlled | 0.532 | ||
No | 129 | 9.3 ± 2.7 | |
Yes | 44 | 9.0 ± 2.6 | |
Treatment type | 0.789 | ||
Chemotherapy | 83 | 9.1 ± 2.8 | |
Targeted | 60 | 9.4 ± 2.7 | |
Othera | 31 | 9.2 ± 2.5 | |
Funding source | 0.729 | ||
Industry | 112 | 9.3 ± 2.7 | |
Other | 62 | 9.1 ± 2.6 | |
Intervention approved for another indication | 0.014 | ||
No | 43 | 10.1 ± 2.9 | |
Yes | 131 | 8.9 ± 2.6 | |
Year of publication | 0.039 | ||
2009 | 49 | 8.6 ± 2.7 | |
2010 | 58 | 9.0 ± 2.4 | |
2011 | 67 | 9.9 ± 2.8 | |
Trial met efficacy endpoint | 0.018 | ||
No | 99 | 8.8 ± 2.4 | |
Yes | 75 | 9.8 ± 3.0 | |
Open access (available free) | 0.210 | ||
No | 35 | 8.7 ± 2.3 | |
Yes | 139 | 9.4 ± 2.8 |